chr16-30953612-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152288.3(ORAI3):c.656C>T(p.Pro219Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,614,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152288.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ORAI3 | NM_152288.3 | c.656C>T | p.Pro219Leu | missense_variant | 2/2 | ENST00000318663.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ORAI3 | ENST00000318663.5 | c.656C>T | p.Pro219Leu | missense_variant | 2/2 | 1 | NM_152288.3 | P1 | |
ORAI3 | ENST00000566237.1 | c.656C>T | p.Pro219Leu | missense_variant | 2/3 | 5 | |||
ORAI3 | ENST00000562699.1 | c.229-2588C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000482 AC: 121AN: 251218Hom.: 0 AF XY: 0.000375 AC XY: 51AN XY: 135842
GnomAD4 exome AF: 0.000391 AC: 572AN: 1461860Hom.: 0 Cov.: 30 AF XY: 0.000370 AC XY: 269AN XY: 727240
GnomAD4 genome AF: 0.000446 AC: 68AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000470 AC XY: 35AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.656C>T (p.P219L) alteration is located in exon 2 (coding exon 2) of the ORAI3 gene. This alteration results from a C to T substitution at nucleotide position 656, causing the proline (P) at amino acid position 219 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at